Surmodics (SRDX) Competitors $39.96 -0.05 (-0.12%) (As of 05:27 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends SRDX vs. IART, ATRC, ATEC, OFIX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying Surmodics stock or one of its competitors? The main competitors of Surmodics include Integra LifeSciences (IART), AtriCure (ATRC), Alphatec (ATEC), Orthofix Medical (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Surmodics vs. Integra LifeSciences AtriCure Alphatec Orthofix Medical AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Surmodics (NASDAQ:SRDX) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and earnings. Does the MarketBeat Community favor SRDX or IART? Integra LifeSciences received 100 more outperform votes than Surmodics when rated by MarketBeat users. However, 63.11% of users gave Surmodics an outperform vote while only 56.83% of users gave Integra LifeSciences an outperform vote. CompanyUnderperformOutperformSurmodicsOutperform Votes33763.11% Underperform Votes19736.89% Integra LifeSciencesOutperform Votes43756.83% Underperform Votes33243.17% Is SRDX or IART more profitable? Integra LifeSciences has a net margin of -0.42% compared to Surmodics' net margin of -9.15%. Integra LifeSciences' return on equity of 12.35% beat Surmodics' return on equity.Company Net Margins Return on Equity Return on Assets Surmodics-9.15% -3.79% -2.55% Integra LifeSciences -0.42%12.35%4.82% Which has better earnings and valuation, SRDX or IART? Integra LifeSciences has higher revenue and earnings than Surmodics. Integra LifeSciences is trading at a lower price-to-earnings ratio than Surmodics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurmodics$126.08M4.54-$11.54M-$0.81-49.33Integra LifeSciences$1.56B1.14$67.74M-$0.09-255.89 Do insiders and institutionals hold more shares of SRDX or IART? 96.6% of Surmodics shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 8.9% of Surmodics shares are owned by insiders. Comparatively, 3.1% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts rate SRDX or IART? Surmodics currently has a consensus price target of $50.00, suggesting a potential upside of 25.13%. Integra LifeSciences has a consensus price target of $23.00, suggesting a potential downside of 0.13%. Given Surmodics' stronger consensus rating and higher probable upside, equities analysts plainly believe Surmodics is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surmodics 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Integra LifeSciences 3 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75 Does the media refer more to SRDX or IART? In the previous week, Surmodics and Surmodics both had 3 articles in the media. Surmodics' average media sentiment score of 1.31 beat Integra LifeSciences' score of 1.12 indicating that Surmodics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surmodics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, SRDX or IART? Surmodics has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. SummarySurmodics beats Integra LifeSciences on 9 of the 17 factors compared between the two stocks. Ad Diversified Trading InstituteCombine the QQQ, IWM and SPY in one tradeIf you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRDX vs. The Competition Export to ExcelMetricSurmodicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$572.63M$4.41B$5.14B$9.30BDividend YieldN/A44.87%4.76%4.06%P/E Ratio-49.3324.87134.4517.49Price / Sales4.5446.601,255.89139.10Price / Cash129.3844.2040.5537.96Price / Book4.807.254.894.91Net Income-$11.54M$13.83M$118.26M$225.23M7 Day Performance0.05%-2.76%14.52%-1.43%1 Month Performance3.20%3.16%17.48%5.40%1 Year Performance5.85%45.90%35.86%22.84% Surmodics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRDXSurmodics4.6268 of 5 stars$39.96-0.1%$50.00+25.1%+6.0%$572.63M$126.08M-49.33376Analyst ForecastNews CoveragePositive NewsIARTIntegra LifeSciences4.0854 of 5 stars$24.09+0.2%$23.00-4.5%-44.6%$1.86B$1.56B-267.003,946News CoveragePositive NewsATRCAtriCure3.6352 of 5 stars$31.72+0.2%$42.00+32.4%-11.6%$1.55B$447.57M-38.161,200Analyst ForecastPositive NewsATECAlphatec3.9809 of 5 stars$9.48-1.5%$17.11+80.5%-29.5%$1.34B$572.74M-7.52700Short Interest ↑Positive NewsOFIXOrthofix Medical2.9554 of 5 stars$18.13+0.9%$23.00+26.9%+48.6%$692.75M$746.64M0.001,634Short Interest ↓Positive NewsANGOAngioDynamics4.4053 of 5 stars$9.42+4.7%$12.00+27.4%+24.7%$382.77M$292.73M-1.51748ARAYAccuray4.6552 of 5 stars$1.96+2.1%$9.00+359.2%-27.0%$197.11M$444.20M-11.29987Positive NewsRMTIRockwell Medical4.2724 of 5 stars$2.06+1.0%$6.00+191.3%+15.2%$66.58M$98.92M-41.20300News CoverageGap UpRSLSReShape Lifesciences1.1389 of 5 stars$4.59-2.8%N/A-76.7%$3.26M$8.68M0.0050Positive NewsGap UpABTAbbott Laboratories4.9335 of 5 stars$113.44+0.1%$130.71+15.2%+5.0%$196.76B$41.22B34.46114,000Dividend IncreaseShort Interest ↑Positive NewsISRGIntuitive Surgical4.7756 of 5 stars$545.16+1.0%$550.28+0.9%+67.1%$194.17B$7.87B86.7513,676Short Interest ↓Positive News Related Companies and Tools Related Companies Integra LifeSciences Competitors AtriCure Competitors Alphatec Competitors Orthofix Medical Competitors AngioDynamics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRDX) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRDX Stock Alerts